Vampire: The Masquerade – Bloodlines 2 Delayed Again

With all its delays and high-profile layoffs, Vampire: The Masquerade – Bloodlines 2 seems to be determined to outclass the original game when it comes to troubled development at least. And that’s quite a feat already.

Driving this absurd point across is this recent announcement that lets us know that Bloodlines 2 is no longer scheduled to launch in 2021, with Hardsuit Labs no longer leading the game’s development.

Here’s the official statement from Paradox:

Good morning, everyone

As you have noticed, we’ve been keeping pretty quiet for a while. With this in mind, the first piece of news we have for you is to confirm that Bloodlines 2 is still in development.

Secondly, we have made the hard decision that Hardsuit Labs will no longer be leading the development of Bloodlines 2 – which also means that we will not be releasing in 2021 as previously planned. Since we cannot at this time communicate a new release date, we’ve also decided to stop accepting pre-orders for the time being.

This game is very important to us and it has been an ambitious project from the very start. In order to meet our goals for it, we’ve come to the conclusion that a change is needed and, as a result, more development time is required.

We’d like to take this opportunity to honor Hardsuit Labs for their efforts and thank them for their hard work on the project. The studio has done a tremendous job in laying the foundations for the game and we hope that you, the community, will also appreciate their contribution to Bloodlines 2.

We’re thankful for your continuous support throughout the game’s development. We understand how important this is to you, and we’d love to share more with you. As soon as we can, we’ll let you know what the future development team of Bloodlines 2 will look like.

Share this article:
Val Hull
Val Hull

Resident role-playing RPG game expert. Knows where trolls and paladins come from. You must fight for your right to gather your party before venturing forth.

Articles: 10020

Leave a Reply

Your email address will not be published. Required fields are marked *